Navigation Links
Introducing Strativa Pharmaceuticals
Date:9/28/2007

Proprietary Products Division of Par Pharmaceutical with Initial Focus on

Supportive Care

WOODCLIFF LAKE, N.J., Sept. 28 /PRNewswire-FirstCall/ - Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced its commitment to developing and marketing novel prescription drugs, through the establishment and introduction of Strativa Pharmaceuticals, its proprietary specialty pharmaceuticals division. Strativa Pharmaceuticals will provide the company's existing proprietary products division with a unique and recognizable identity in the marketplace -- to both healthcare providers and payers, as well as potential partners.

"Par has a long tradition of developing, manufacturing and marketing high-quality pharmaceuticals," said Patrick G. LePore, chairman, chief executive officer and president of Par. "Our Generics Division is a leader among U.S. generic drug companies, and we envision Strativa becoming a preeminent specialty pharmaceutical company. Strativa's unique focus will be to bring innovative proprietary pharmaceuticals to market. We consider this approach the best way to serve the needs of patients, while addressing unmet medical needs."

Strativa's current focus is on supportive care products for patients who are often critically ill. These therapeutics help patients manage complications from their illnesses or from the treatments they are receiving for those illnesses. Strativa's initial product offerings will be in HIV and oncology.

"Strativa is committed to providing treatment options to patients and their healthcare providers," said John A. MacPhee, president of Strativa Pharmaceuticals. "Our proprietary organization combines the energy and innovation of a ne
'/>"/>

SOURCE Strativa Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Introducing GenElute HP Endotoxin-Free Plasmid Maxiprep Kit
2. Johnson Controls introducing new building controls system
3. Deltanoid Pharmaceuticals begins phase II osteoporosis study
4. The Coming of Biotech Generic Pharmaceuticals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... A mechanised blue dye te...on to packaging quality assurance one step closer ...-contact leak testing machine developed by Seph...een installed in several local and global pharma-c...o address quality assurance and productivity impro...
(Date:11/25/2009)..., , BOSTON, Nov. 25 B... H1N1 virus, genomic data from the 1918 pandemic t...he current H1N1 pandemic, today issued its latest ...ows that the lethality of the H1N1 ("Swine Flu") v...uring the virus,s current outbreak in the spring o...
(Date:11/25/2009)..., , MARKHAM, ON, Nov. 25 /PRNewswire/ - Cyt...oldt, PhD to its Board of Directors. Dr. Moldt wil...tative on the Company,s Board. The number of Board...We are very pleased to welcome Peter Moldt to the ...rience and guidance as Cytochroma continues to mak...
(Date:11/25/2009)..., , SAN DIEGO, Nov. 25 /PRNewswire-FirstCa...nounced today that Barry D. Quart, Pharm.D., presi...the Piper Jaffray 21st Annual Health Care Conferen...r Jaffray 21st Annual Health Care Conference,Date:...m. Eastern Time,Location: The New York Palace Hot...
Breaking Biology Technology:Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...t the promise of Silicon Valley has joined the doo...opriate time to revisit the importance of technolo...ions of dollars have been spent on marketing the s... must come into a business or industry than goes o...g about technology that matters is what people and...
...ing back, you couldn,t tell it by the Consumer Ele... product releases, a near-electric buzz among atte...een at a technology tradeshow in recent years. In ...omic indicator, this market is coming back strong....nes more reliable than the wait for a hackney. , ...
...o everything these days - from removing tattoos to... dairy state of Wisconsin, lasers have been harnes...,Xiaochun Li, a University of Wisconsin-Madison me...long with graduate student Hongseok Choi, has beco...ining" technique, primarily used in laser eye surg...
Other Biology Technology:Look at the New Economy, Just Like the Old Economy 2Consumers Lead Tech Market Comeback 2Consumers Lead Tech Market Comeback 3Wisconsin Engineers Devise Cutting-Edge Method to Cut Cheese 2Wisconsin Engineers Devise Cutting-Edge Method to Cut Cheese 3
(Date:11/30/2009)... PITTSBURGHA University of Pittsburgh team overca...materials such as those that could lead to more ef...der car exhaust less toxic. The researchers report...ration of high-temperature stability in metallic n...s hampered by a vulnerability to extreme heat. , ...
(Date:11/30/2009)... The Editors of The Journal of Experimental Biol... from Centre National de la Recherche Scientifique...is the winner of this year,s JEB Outstanding Pap...an outstanding achievement and is intended to enco... JEB Editor-in-Chief, and adds that ,we truly app...
(Date:11/30/2009)... Take advantage of lower early bird registration ...eoporosis congress of 2010 at http://www.iofwco-e... congress of the International Osteoporosis Founda...nd Economic Aspects of Osteoporosis and Osteoarthr...ound the world are expected to attend. The excitin...
Breaking Biology News(10 mins):First metallic nanoparticles resistant to extreme heat 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4School of Health Management Honors 162 Graduating Students 51979 1School of Health Management Honors 162 Graduating Students 51979 2Essilor 3A First Half 2009 Revenue 13074 1Essilor 3A First Half 2009 Revenue 13074 2Essilor 3A First Half 2009 Revenue 13074 3Essilor 3A First Half 2009 Revenue 13074 4Essilor 3A First Half 2009 Revenue 13074 5Is a society with smokers profitable 3F 51975 1Is a society with smokers profitable 3F 51975 2Is a society with smokers profitable 3F 51975 3
...nguists have argued that certain patterns of langu...ans -- perhaps the only uniquely human component o...hicago and the University of California San Diego ...h patterns and distinguish between them in Sturnus...April 27, 2006, issue of Nature, the researchers s...
...have discovered that a dominant hyena puts her cub...assing on high levels of certain hormones that mak...xually advanced. , The report, published in the Ap...als to demonstrate a relationship between a female...fspring,s behavior through prenatal hormone transf...
...t can harm the brain immediately after a stroke ma...new research. Insights from the study could change...or effective treatment from a couple of hours to a...s for drug development. , Working with rats, a te...Radiology and Neurology found that the enzyme matr...
Other Biology News:'Uniquely human' component of language found in gregarious birds 2'Uniquely human' component of language found in gregarious birds 3'Uniquely human' component of language found in gregarious birds 4'Uniquely human' component of language found in gregarious birds 5'Bad' enzymes may wear white hats after stroke 2'Bad' enzymes may wear white hats after stroke 3'Bad' enzymes may wear white hats after stroke 4
...in plasma from juvenile or male fish is a simple a...emicals (EDCs) with estrogenic effects in fish. Qu...ng test for the estrogenic effects of EDCs in fish...body immunometric (sandwich) EIA for analyzing Vtg...
...ic peptide whose sequence corresponds to residues ...e is (amino to carboxy terminus): V115 - L - P - ...- G - P - E133 (C) (The C-terminal cysteine has be...rt of the native rat SAP97 sequence.). This pept...
...ls were designed for full-length gene cloning and ...sired cDNA clone. The first PCR analysis is perfor...ontains plasmid DNA from 5,000 clones. Having iden... of the reaction products, the second PCR analysis...
...ls were designed for full-length gene cloning and ...sired cDNA clone. The first PCR analysis is perfor...ontains plasmid DNA from 5,000 clones. Having iden... of the reaction products, the second PCR analysis...
Biology Products: